Mammalian cell cultivation is routinely used to produce recombinant proteins or monoclonal antibodies (mAbs) for diagnostic and clinical applications. Since 1980 the productivity of mammalian cells ...
The Business Research Company's Hollow-Fiber Bioreactors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Get 30% Off All Global Market Reports With Code ONLINE30 – Stay ...
Current potential bioprocess solutions for the scaleup of adherent cells include cell stacks, robotic flask handling, packed-bed culture, hollow-fiber bioreactors, and microcarriers or aggregate ...
The hollow fiber bioreactor-disposable set is a highly efficient bioreactor configuration suitable for small scale biomass or protein production. The heart of the bioreactor is the hollow fiber module ...
TAMPA, Fla. & MINNEAPOLIs--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: "BVTI"), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: "ABPI"), today announced that Biovest ...
Researchers have developed a hollow fiber bioreactor that mimics a circulatory system, overcoming challenges in tissue thickness and nutrient delivery. This breakthrough enables the scalable ...
Biovest and U.S. Army Enter into Collaborative Agreement to Develop Novel Bioreactor Systems as Platform Technology for Production of Anti-Viral Vaccines and Drugs TAMPA, Fla. & MINNEAPOLIS, Apr 23, ...
One of the most important advances in the field of cell biology came in the early 20th century, with the discovery that plant and animal cells could survive - and even replicate - outside the living ...
A bioreactor that mimics a circulatory system can deliver nutrients and oxygen to artificial tissue, enabling the production of over 10 grams of chicken muscle for cultured meat applications. A ...
The combination of embryonic porcine liver (E35) cells and pulsing a high concentration of hepatocytes growth factor (HGF) in radial flow bioreactor (RFB) provided a system for which clinical ...
TAMPA, Fla. & MINNEAPOLIs--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: "BVTI"), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: "ABPI"), today announced that Biovest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback